Imaging hypoxia in endometrial cancer: How and why should it be done?

Front Oncol. 2022 Nov 9:12:1020907. doi: 10.3389/fonc.2022.1020907. eCollection 2022.

Nandita M deSouza^{1

2}, Ananya Choudhury^{3

4}, Mel Greaves⁵, James P B O'Connor^{1

2

4}, Peter J Hoskin^{4

6}

¹ Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom.
² Department of Imaging, The Royal Marsden National Health Service (NHS) Foundation Trust, London, United Kingdom.
³ Radiation Oncology, The Christie National Health Service (NHS) Foundation Trust Manchester, Manchester, United Kingdom.
⁴ The Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom.
⁵ Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.
⁶ Radiation Oncology, Mount Vernon Cancer Centre, Northwood, United Kingdom.

No abstract available

Keywords: endometrial cancer; hypoxia; magnetic resonance imaging (MRI); molecular subtypes; oxygen-enhanced MRI.

Grants and funding